Literature DB >> 22190362

Rare variants in the CYP27B1 gene are associated with multiple sclerosis.

Sreeram V Ramagopalan1, David A Dyment, M Zameel Cader, Katie M Morrison, Giulio Disanto, Julia M Morahan, Antonio J Berlanga-Taylor, Adam Handel, Gabriele C De Luca, A Dessa Sadovnick, Pierre Lepage, Alexandre Montpetit, George C Ebers.   

Abstract

OBJECTIVE: Multiple sclerosis (MS) is a complex neurological disease. Genetic linkage analysis and genotyping of candidate genes in families with 4 or more affected individuals more heavily loaded for susceptibility genes has not fully explained familial disease clustering.
METHODS: We performed whole exome sequencing to further understand the heightened prevalence of MS in these families.
RESULTS: Forty-three individuals with MS (1 from each family) were sequenced to find rare variants in candidate MS susceptibility genes. On average, >58,000 variants were identified in each individual. A rare variant in the CYP27B1 gene causing complete loss of gene function was identified in 1 individual. Homozygosity for this mutation results in vitamin D-dependent rickets I (VDDR1), whereas heterozygosity results in lower calcitriol levels. This variant showed significant heterozygous association in 3,046 parent-affected child trios (p = 1 × 10(-5)). Further genotyping in >12,500 individuals showed that other rare loss of function CYP27B1 variants also conferred significant risk of MS, Peto odds ratio = 4.7 (95% confidence interval, 2.3-9.4; p = 5 × 10(-7)). Four known VDDR1 mutations were identified, all overtransmitted. Heterozygous parents transmitted these alleles to MS offspring 35 of 35× (p = 3 × 10(-9)).
INTERPRETATION: A causative role for CYP27B1 in MS is supported; the mutations identified are known to alter function having been shown in vivo to result in rickets when 2 copies are present. CYP27B1 encodes the vitamin D-activating 1-alpha hydroxylase enzyme, and thus a role for vitamin D in MS pathogenesis is strongly implicated.
Copyright © 2011 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22190362     DOI: 10.1002/ana.22678

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  83 in total

1.  Multiple sclerosis: Multiple sclerosis therapy--vitamin D under spotlight.

Authors:  Iley Ozerlat
Journal:  Nat Rev Neurol       Date:  2012-03-20       Impact factor: 42.937

Review 2.  The genetics of multiple sclerosis: an up-to-date review.

Authors:  Pierre-Antoine Gourraud; Hanne F Harbo; Stephen L Hauser; Sergio E Baranzini
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

3.  Functional genomics analysis of vitamin D effects on CD4+ T cells in vivo in experimental autoimmune encephalomyelitis ‬.

Authors:  Manuel Zeitelhofer; Milena Z Adzemovic; David Gomez-Cabrero; Petra Bergman; Sonja Hochmeister; Marie N'diaye; Atul Paulson; Sabrina Ruhrmann; Malin Almgren; Jesper N Tegnér; Tomas J Ekström; André Ortlieb Guerreiro-Cacais; Maja Jagodic
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-14       Impact factor: 11.205

4.  Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus.

Authors:  Linda Ottoboni; Irene Y Frohlich; Michelle Lee; Brian C Healy; Brendan T Keenan; Zongqi Xia; Tanuja Chitnis; Charles R Guttmann; Samia J Khoury; Howard L Weiner; David A Hafler; Philip L De Jager
Journal:  Neurology       Date:  2013-10-30       Impact factor: 9.910

Review 5.  Metabolites: deciphering the molecular language between DCs and their environment.

Authors:  Lucía Minarrieta; Peyman Ghorbani; Tim Sparwasser; Luciana Berod
Journal:  Semin Immunopathol       Date:  2016-12-05       Impact factor: 9.623

6.  Replication study of GWAS risk loci in Greek multiple sclerosis patients.

Authors:  Georgios M Hadjigeorgiou; Persia-Maria Kountra; Georgios Koutsis; Vana Tsimourtou; Vasileios Siokas; Maria Dardioti; Dimitrios Rikos; Chrysoula Marogianni; Athina-Maria Aloizou; Georgia Karadima; Styliani Ralli; Nikolaos Grigoriadis; Dimitrios Bogdanos; Marios Panas; Efthimios Dardiotis
Journal:  Neurol Sci       Date:  2018-10-26       Impact factor: 3.307

Review 7.  Application of next-generation sequencing technologies in Neurology.

Authors:  Teng Jiang; Meng-Shan Tan; Lan Tan; Jin-Tai Yu
Journal:  Ann Transl Med       Date:  2014-12

8.  Targeted genomic deletions identify diverse enhancer functions and generate a kidney-specific, endocrine-deficient Cyp27b1 pseudo-null mouse.

Authors:  Mark B Meyer; Nancy A Benkusky; Martin Kaufmann; Seong Min Lee; Robert R Redfield; Glenville Jones; J Wesley Pike
Journal:  J Biol Chem       Date:  2019-05-03       Impact factor: 5.157

Review 9.  Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.

Authors:  S Binks; R Dobson
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

10.  Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls.

Authors:  Pavan Bhargava; Sonya U Steele; Emmanuelle Waubant; Nisha R Revirajan; Jacqueline Marcus; Marieme Dembele; Sandra D Cassard; Bruce W Hollis; Ciprian Crainiceanu; Ellen M Mowry
Journal:  Mult Scler       Date:  2015-08-18       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.